UBS has initiated coverage on CareTrust REIT Inc (CTRE) with a Buy rating, marking the firm's first assessment of the company. This move underscores UBS's confidence in CareTrust's investment potential based on their research and analysis of the healthcare real estate sector.
Headquartered in San Clemente, California, CareTrust REIT engages in the ownership, acquisition, and leasing of healthcare-related properties. The company boasts a portfolio that includes skilled nursing facilities, assisted living, and independent living properties across the United States and the United Kingdom. As of November 17, 2025, CareTrust's stock is priced at $36.91, with a market capitalization of $8.1 billion and a P/E ratio of 31.08.
Upcoming earnings reports are anticipated, with estimates of $0.40 EPS and $119.0 million in revenue for August 3, 2026. Analyst consensus indicates a positive outlook, with 6 Strong Buy, 7 Buy, and 3 Hold ratings among a total of 16 analysts.
Analyst ratings can provide valuable insights, yet they are based on estimates that may not always materialize. Investors should consider a variety of factors, including company fundamentals and industry trends, before making investment decisions. Rating changes can occur as new information becomes available, highlighting the dynamic nature of market evaluations.